TokenPost topic
1 TokenPost story is tagged TRITON-CM. The newest appear first.
The change concerns TRITON-CM, a Phase 3 trial of nucresiran, Alnylam's next-generation RNAi therapeutic.
Oct 30, 2026, 12:42 PM EDT ยท Investing